tiprankstipranks
Better Therapeutics, Inc. (BTTX)
OTHER OTC:BTTX
US Market

Better Therapeutics, Inc. (BTTX) Income Statement

Compare
170 Followers

Better Therapeutics, Inc. Income Statement

Last quarter (Q3 2023), Better Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Better Therapeutics, Inc.'s net income was $-5.86M. See Better Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 8.00K$ 18.00K
Gross Profit
$ -2.73M$ -1.62M$ -674.00K$ -880.00K
Operating Expenses
$ 38.26M$ 30.56M$ 5.65M$ 4.89M
Depreciation and Amortization
$ 2.73M$ 1.62M$ 75.00K$ 72.00K
EBITDA
$ -38.26M$ -30.56M$ -6.25M$ -5.70M
Operating Income
$ -38.26M$ -30.56M$ -6.32M$ -5.77M
Other Income/Expenses
$ -1.49M$ -9.93M$ 89.00K$ -11.00K
Pretax Income
$ -39.75M$ -40.49M$ -6.23M$ -5.78M
Net Income
$ -39.76M$ -40.34M$ -6.39M$ -5.79M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -1.69$ -1.71$ -0.85$ -0.25
Diluted EPS
$ -1.69$ -1.71$ -0.85$ -0.25
Weighted Average Shares Outstanding
23.56M 23.60M 7.56M 23.60M
Weighted Average Shares Outstanding (Diluted)
23.56M 23.60M 7.56M 23.60M
Currency in USD

Better Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis